218 related articles for article (PubMed ID: 8704637)
1. [The pharmacological properties of preparations from the aziridinyl triazine group].
Stukov AN; Filov VA; Kon'kov SA; Ivin BA
Eksp Klin Farmakol; 1996; 59(1):58-60. PubMed ID: 8704637
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor activity and pharmacological properties of furizil].
Stukov AN; Kraĭz BO; Aleksandrov VA; Ivin BA; Filov VA
Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130
[TBL] [Abstract][Full Text] [Related]
3. [Effect of dioxadet on tumors transplanted to the brain].
Stukov AN; Korsakov MV; Khrapova TN; Kil'maeva NE; Kraĭz BO
Vopr Onkol; 1986; 32(10):64-7. PubMed ID: 3776129
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
WU FY; Le Pecq JB
Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
[No Abstract] [Full Text] [Related]
5. [The antitumor properties of honey].
Gribel' NV; Pashinskiĭ VG
Vopr Onkol; 1990; 36(6):704-9. PubMed ID: 2378090
[TBL] [Abstract][Full Text] [Related]
6. Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism.
Conn HO; Creasey WA; Calabresi P
Cancer Res; 1967 Apr; 27(4):618-25. PubMed ID: 6071670
[No Abstract] [Full Text] [Related]
7. [Preclinical studies for development of anti-cancer drugs: current and historical status and problems].
Okabe M; Kobayashi S; Hirata T; Nakano H; Ikegami J; Inoue K; Komuro T
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():302-9. PubMed ID: 7986108
[TBL] [Abstract][Full Text] [Related]
8. Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice.
Maeda M; Ligo M; Tsuda H; Fujita H; Yonemura Y; Nakagawa K; Endo Y; Sasaki T
Anticancer Drug Des; 2000 Jun; 15(3):217-23. PubMed ID: 11049089
[TBL] [Abstract][Full Text] [Related]
9. Tirapazamine-induced cytotoxicity and DNA damage in transplanted tumors: relationship to tumor hypoxia.
Siim BG; Menke DR; Dorie MJ; Brown JM
Cancer Res; 1997 Jul; 57(14):2922-8. PubMed ID: 9230202
[TBL] [Abstract][Full Text] [Related]
10. General pharmacology of cis-malonato[4R,5R)-4,5-bis-(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II).
Kim DK; Ahn JS; Ryu G; Kim KH; Park CW; Kim MS; Chung MH; Shin SG; Suh YH; Kim YS
Arzneimittelforschung; 1994 Sep; 44(9):1080-8. PubMed ID: 7986249
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacology and possible mechanism of action of the novel antitumor agent 5-(4'-piperidinomethylphenyl)-2,3-dihydroimidazo [2,1-a]isoquinoline.
Houlihan WJ; Munder PG; Handley DA; Nemecek GA
Arzneimittelforschung; 1995 Oct; 45(10):1133-7. PubMed ID: 8595076
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study of the antitumor properties of olipifat].
Filov VA; Reztsova VV; Kil'maeva NE; Petukhov DV; Pinchuk BT
Vopr Onkol; 2000; 46(3):332-6. PubMed ID: 10976281
[TBL] [Abstract][Full Text] [Related]
13. Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.
Bincoletto C; Tersariol IL; Oliveira CR; Dreher S; Fausto DM; Soufen MA; Nascimento FD; Caires AC
Bioorg Med Chem; 2005 Apr; 13(8):3047-55. PubMed ID: 15781414
[TBL] [Abstract][Full Text] [Related]
14. [Methodical aspects in studies on the carcinogenesis and chemotherapy of tumors].
Schmähl D
Planta Med; 1968; ():3-12. PubMed ID: 4976078
[No Abstract] [Full Text] [Related]
15. [Multicenter clinical trial of the antitumor drug Dioxadet (phase II)].
Gershanovich ML; Filov VA; Kotova DG; Stukov AN; Sokolov IuN; Ivin BA
Vopr Onkol; 1998; 44(2):216-20. PubMed ID: 9615831
[TBL] [Abstract][Full Text] [Related]
16. [Anticarcinogenic and antitumor properties of selenium-containing phenol derivatives].
Didzhiapetrene IaK; Shukialene DF; Dzhiuvene DA; Degutis IuA
Eksp Onkol; 1988; 10(6):57-9. PubMed ID: 3243198
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacological properties and antitumor activity of a preparation diiodo-benzo-tepa in experiments].
Trinus FP; Sologub PY; Protsenko LD; Tarnavskaya MI; Nikolaeva SV; Danilenko VS; Sharykina NI; Kolodyazhny VI; Zaikina RG; Goncharenko GV; Kopel'nik MA; Andrianova SM
Vopr Onkol; 1979; 25(9):53-8. PubMed ID: 90429
[TBL] [Abstract][Full Text] [Related]
18. [The effect of zymosan on the toxicity and activity of various antitumor preparations].
Veksler IG
Vopr Onkol; 1966; 12(8):80-6. PubMed ID: 4972211
[No Abstract] [Full Text] [Related]
19. Hypoxia-selective 3-alkyl 1,2,4-benzotriazine 1,4-dioxides: the influence of hydrogen bond donors on extravascular transport and antitumor activity.
Hay MP; Pchalek K; Pruijn FB; Hicks KO; Siim BG; Anderson RF; Shinde SS; Phillips V; Denny WA; Wilson WR
J Med Chem; 2007 Dec; 50(26):6654-64. PubMed ID: 18052317
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy.
Hoffman RM
Methods Mol Med; 2005; 111():297-322. PubMed ID: 15911987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
